PMID- 19228761 OWN - NLM STAT- MEDLINE DCOM- 20090825 LR - 20220409 IS - 1460-2350 (Electronic) IS - 0268-1161 (Linking) VI - 24 IP - 6 DP - 2009 Jun TI - Endometrial secretion analysis identifies a cytokine profile predictive of pregnancy in IVF. PG - 1427-35 LID - 10.1093/humrep/dep011 [doi] AB - BACKGROUND: The study of human endometrial-embryonic interactions is complicated by the disruptive impact of endometrial sample collection on the process of implantation itself. Endometrial secretion analysis is a novel technique, non-disruptive to implantation. The primary aim of this prospective cohort study was to explore whether a cytokine profile predictive of implantation and clinical pregnancy can be identified in endometrial secretions aspirated immediately prior to embryo transfer following IVF. METHODS: Endometrial secretions, aspirated immediately prior to embryo transfer from 210 women undergoing IVF, were analyzed using a multiplex immunoassay for 17 soluble regulators of implantation, namely interleukin (IL)-1beta, IL-5, IL-6, IL-10, IL-12, IL-15, IL-17, IL-18, tumor necrosis factor (TNF)-alpha, interferon (IFN)-gamma, macrophage migration inhibitory factor, eotaxin, IFN-gamma-inducible 10 kDa protein (IP-10), monocyte chemo-attractant protein-1 (MCP-1), Dickkopf homolog 1, heparin-binding epidermal growth factor and vascular endothelial growth factor (VEGF). In order to detect implantation, daily urine samples were collected after embryo transfer, and human Chorionic Gonadotropin (hCG) concentrations were analyzed by an immunoassay. RESULTS: Multivariable logistic regression analysis revealed significant associations (negative and positive association, respectively) between MCP-1 (P = 0.005) and IP-10 (P = 0.037) levels and implantation, and between IL-1beta (P = 0.047) and TNF-alpha (P = 0.023) levels and clinical pregnancy. The predictive value for pregnancy of IL-1beta and TNF-alpha was observed to be equivalent and additive to that of embryo quality. CONCLUSIONS: Endometrial secretion cytokine profiling offers a novel, non-disruptive approach to study the role of the endometrium in human embryo implantation and identifies a profile which appears to be conducive to clinical pregnancy. CLINICAL TRIAL REGISTRATION: www.clinicaltrials.gov (nCT00264992). FAU - Boomsma, C M AU - Boomsma CM AD - Department of Reproductive Medicine and Gynecology, University Medical Center Utrecht, F05.126, PO Box 85500, 3508 GA, Utrecht, The Netherlands. c.m.boomsma@umcutrecht.nl FAU - Kavelaars, A AU - Kavelaars A FAU - Eijkemans, M J C AU - Eijkemans MJ FAU - Lentjes, E G AU - Lentjes EG FAU - Fauser, B C J M AU - Fauser BC FAU - Heijnen, C J AU - Heijnen CJ FAU - Macklon, N S AU - Macklon NS LA - eng SI - ClinicalTrials.gov/NCT00264992 PT - Clinical Trial PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20090219 PL - England TA - Hum Reprod JT - Human reproduction (Oxford, England) JID - 8701199 RN - 0 (Biomarkers) RN - 0 (Cytokines) SB - IM MH - Adult MH - Area Under Curve MH - Biomarkers/metabolism MH - Cytokines/*metabolism MH - Embryo Implantation/immunology MH - Embryo Transfer MH - Endometrium/*immunology/*metabolism MH - Female MH - Fertilization in Vitro/*methods MH - Humans MH - Immunoassay/*methods MH - Logistic Models MH - Multivariate Analysis MH - Predictive Value of Tests MH - Pregnancy MH - Pregnancy Outcome MH - Prospective Studies EDAT- 2009/02/21 09:00 MHDA- 2009/08/26 09:00 CRDT- 2009/02/21 09:00 PHST- 2009/02/21 09:00 [entrez] PHST- 2009/02/21 09:00 [pubmed] PHST- 2009/08/26 09:00 [medline] AID - dep011 [pii] AID - 10.1093/humrep/dep011 [doi] PST - ppublish SO - Hum Reprod. 2009 Jun;24(6):1427-35. doi: 10.1093/humrep/dep011. Epub 2009 Feb 19.